BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18355764)

  • 1. Wnt signaling pathway and lung disease.
    Van Scoyk M; Randall J; Sergew A; Williams LM; Tennis M; Winn RA
    Transl Res; 2008 Apr; 151(4):175-80. PubMed ID: 18355764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diseases of Wnt signaling.
    Johnson ML; Rajamannan N
    Rev Endocr Metab Disord; 2006 Jun; 7(1-2):41-9. PubMed ID: 16944325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling in stem cells and non-small-cell lung cancer.
    He B; Barg RN; You L; Xu Z; Reguart N; Mikami I; Batra S; Rosell R; Jablons DM
    Clin Lung Cancer; 2005 Jul; 7(1):54-60. PubMed ID: 16098245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wnt/beta-catenin signaling pathway as a target in drug discovery.
    Takahashi-Yanaga F; Sasaguri T
    J Pharmacol Sci; 2007 Aug; 104(4):293-302. PubMed ID: 17721040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt signaling in prostate development and carcinogenesis.
    Kharaishvili G; Simkova D; Makharoblidze E; Trtkova K; Kolar Z; Bouchal J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Mar; 155(1):11-8. PubMed ID: 21475372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Wnt signaling in cancer and stem cells.
    Reguart N; He B; Taron M; You L; Jablons DM; Rosell R
    Future Oncol; 2005 Dec; 1(6):787-97. PubMed ID: 16556058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signaling in stem cells and lung cancer.
    He B; Jablons DM
    Ernst Schering Found Symp Proc; 2006; (5):27-58. PubMed ID: 17939294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
    Mikesch JH; Steffen B; Berdel WE; Serve H; Müller-Tidow C
    Leukemia; 2007 Aug; 21(8):1638-47. PubMed ID: 17554387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt signaling and cancer development: therapeutic implication.
    Paul S; Dey A
    Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Winding through the WNT pathway during cellular development and demise.
    Li F; Chong ZZ; Maiese K
    Histol Histopathol; 2006 Jan; 21(1):103-24. PubMed ID: 16267791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WNT signaling in lung disease: a failure or a regeneration signal?
    Königshoff M; Eickelberg O
    Am J Respir Cell Mol Biol; 2010 Jan; 42(1):21-31. PubMed ID: 19329555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNT signaling pathway and stem cell signaling network.
    Katoh M; Katoh M
    Clin Cancer Res; 2007 Jul; 13(14):4042-5. PubMed ID: 17634527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
    Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
    J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT receptor signalling in lung physiology and pathology.
    Skronska-Wasek W; Gosens R; Königshoff M; Baarsma HA
    Pharmacol Ther; 2018 Jul; 187():150-166. PubMed ID: 29458107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells.
    Zhang X; Lou Y; Wang H; Zheng X; Dong Q; Sun J; Han B
    Med Oncol; 2015 Apr; 32(4):95. PubMed ID: 25731617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/beta-catenin signaling pathway as a novel cancer drug target.
    Luu HH; Zhang R; Haydon RC; Rayburn E; Kang Q; Si W; Park JK; Wang H; Peng Y; Jiang W; He TC
    Curr Cancer Drug Targets; 2004 Dec; 4(8):653-71. PubMed ID: 15578921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Wnt/beta-catenin signaling in renal carcinogenesis: lessons from cadmium toxicity studies.
    Thévenod F; Chakraborty PK
    Curr Mol Med; 2010 Jun; 10(4):387-404. PubMed ID: 20455852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
    Prosperi JR; Goss KH
    Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAK and WNT signaling: the meeting of two pathways in cancer and development.
    Fonar Y; Frank D
    Anticancer Agents Med Chem; 2011 Sep; 11(7):600-6. PubMed ID: 21707509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
    Chen B; Dodge ME; Tang W; Lu J; Ma Z; Fan CW; Wei S; Hao W; Kilgore J; Williams NS; Roth MG; Amatruda JF; Chen C; Lum L
    Nat Chem Biol; 2009 Feb; 5(2):100-7. PubMed ID: 19125156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.